Mavrouli M, Vrioni G, Vlahakis A, Kapsimali V, Mavroulis S, Antypas A, Tsakris A, 2015. West Nile virus: biology, transmission, clinical manifestations, diagnosis, therapeutic approaches, climatic correlates and prevention. Acta Microbiol Hellenica 60: 7ā34.
Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, Davis B, Bowen R, Bunning M, 2003. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9: 311ā322.
Molaei G, Andreadis TG, Armstrong PM, Anderson JF, Vossbrinck CR, 2006. Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis 12: 468ā474.
Marka A et al. 2013. West Nile virus state of the art report of MALWEST project. Int J Environ Res Public Health 10: 6534ā6610.
Colpitts TM, Conway MJ, Montgomery RR, Fikrig E, 2012. West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev 25: 635ā648.
Petersen LR, Marfin AA, 2002. West Nile virus: a primer for the clinician. Ann Intern Med 137: 173ā179.
Smithburn KC, Hughes TP, Burke AW, Paul JH, 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 20: 471ā473.
Gubler DJ, 2007. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45: 1039ā1046.
Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI, 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet 352: 767ā771.
Platonov AE et al. 2001. Outbreak of West Nile virus infection, Volgograd region, Russia, 1999. Emerg Infect Dis 7: 128ā132.
Nash D et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807ā1814.
Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R, 2010. Epidemiology of West Nile in Europe and in the Mediterranean basin. Open Virol J 4: 29ā37.
Papa A et al. 2010. Ongoing outbreak of West Nile virus infections in humans in Greece, JulyāAugust 2010. Euro Surveill 15: 1ā5, pii: 19644.
Danis K et al. 2011. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis 17: 1868ā1872.
Vrioni G, Mavrouli M, Kapsimali V, Stavropoulou A, Detsis M, Danis K, Tsakris A, 2014. Laboratory and clinical characteristics of human West Nile virus infections during 2011 outbreak in southern Greece. Vector Borne Zoonotic Dis 14: 52ā58.
Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE, 2004. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol 42: 4641ā4648.
Prince HE, Lapeā-Nixon M, Moore RJ, Hogrefe WR, 2004. Utility of the focus technologies West Nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol 42: 12ā15.
Hadjichristodoulou C et al. 2015. West Nile Virus seroprevalence in the Greek population in 2013: a nationwide cross-sectional survey. PLoS One 10: e0143803.
Paz S, Semenza JC, 2013. Environmental drivers of West Nile fever epidemiology in Europe and western Asiaāa review. Int J Environ Res Public Health 10: 3543ā3562.
Lanciotti RS et al. 1999. Origin of West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333ā2337.
Papa A, Bakonyi T, Xanthopoulou K, Vazquez A, Tenorio A, Nowotny N, 2011. Genetic characterization of West Nile virus lineage 2, Greece 2010. Emerg Infect Dis 17: 920ā922.
Barzon L et al. 2013. Genome sequencing of West Nile virus from human cases in Greece, 2012. Viruses 5: 2311ā2319.
Danis K et al. 2011. Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill 16: 1ā5, pii: 19951.
Chaintoutis SC, Gewehr S, Mourelatos S, Dovas CI, 2016. Serological monitoring of backyard chickens in central Macedonia-Greece can detect low transmission of West Nile virus in the absence of human neuroinvasive disease cases. Acta Trop 163: 26ā31.
ECDC, 2017. West Nile FeverāAnnual Epidemiological Report for 2015. Available at: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-West-Nile-fever.pdf. Accessed April 10, 2018.
Nur YA, Groen J, Heuvelmans H, Tuynman W, Copra C, Osterhaus AD, 1999. An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg 61: 885ā888.
ECDC, 2018. Epidemiological Update: West Nile Virus Transmission Season in Europe, 2017. Available at: https://ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-virus-transmission-season-europe-2017. Accessed April 10, 2018.
Anis E, Grotto I, Mendelson E, Bin H, Orshan L, Gandacu D, Warshavsky B, Shinar E, Slater PE, Lev B, 2014. West Nile fever in Israel: the reemergence of an endemic disease. J Infect 68: 170ā175.
Bernabeu-Wittel M, Ruiz-Perez M, del Toro MD, Aznar J, Muniain A, de Ory F, Domingo C, Pachon J, 2007. West Nile virus past infections in the general population of southern Spain. Enferm Infecc Microbiol Clin 25: 561ā565.
Pervanidou D et al. 2014. West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission. Euro Surveill 19: 1ā11, pii: 20758.
Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, 2002. West Nile virus. Lancet Infect Dis 2: 519ā529.
Murray K et al. 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325ā1332.
Pezzotti P et al. 2011. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill 16: 1ā5, pii: 19814.
Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR, 2011. Flavivirus-induced antibody cross-reactivity. J Gen Virol 92: 2821ā2829.
Gaibani P, Rossini G, 2017. An overview of Usutu virus. Microbes Infect 19: 382ā387.
Chaintoutis SC et al. 2014. Evaluation of a West Nile virus surveillance and early warning system in Greece, based on domestic pigeons. Comp Immunol Microbiol Infect Dis 37: 131ā141.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 51 | 51 | 10 |
Full Text Views | 532 | 126 | 1 |
PDF Downloads | 218 | 49 | 1 |
Greece experienced the largest European West Nile virus (WNV) outbreak in 2010 since the 1996 Romania epidemic. West Nile virus reemerged in southern Greece during 2017, after a 2-year hiatus of recorded human cases, and herein laboratory findings, clinical features, and geographic distribution of WNV cases are presented. Clinical specimens from patients with clinically suspected WNV infection were sent from local hospitals to the Microbiology Department of Medical School, National and Kapodistrian University of Athens, and were tested for the presence of specific anti-WNV antibodies and WNV RNA. From July to September 2017, 45 confirmed or probable WNV infection cases were identified; 43 of them with an acute/recent infection, of which 24 (55.8%) experienced WNV neuroinvasive disease (WNND). Risk factors for developing WNND included advanced age, hypertension, and diabetes mellitus. A total of four deaths (16.7%) occurred, all in elderly patients aged > 70 years. Thirty-nine cases were identified in regional units that had not been affected before (36 in Argolis and two in Corinth, northeastern Peloponnese, and one in Rethymno, Crete). The remaining four cases were reported from previously affected regional units of northwestern Peloponnese. The reemergence of WNV after a 2-year hiatus of recorded human cases and the spread of the virus in newly affected regions of the country suggests that WNV has been established in Greece and disease transmission will continue in the future. Epidemiological surveillance, intensive mosquito management programs, and public awareness campaigns about personal protective measures are crucial to the prevention of WNV transmission.
Authorsā addresses: Maria Mavrouli, Georgia Vrioni, Violetta Kapsimali, Constantinos Tsiamis, and Athanassios Tsakris, Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece, E-mails: mmavrouli@med.uoa.gr, gvrioni@med.uoa.gr, vkapsimali@med.uoa.gr, ctsiamis@med.uoa.gr, and atsakris@gmail.com. Spyridon Mavroulis, Department of Dynamic Tectonic Applied Geology, Faculty of Geology and Geoenvironment, National and Kapodistrian University of Athens, Athens, Greece, E-mail: smavroulis@geol.uoa.gr. Danai Pervanidou, Hellenic Center for Disease Control and Prevention, Department of Epidemiological Surveillance and Intervention, Vector-borne Diseases Office, Athens, Greece, E-mail: pervanidou.keelpno@gmail.com. Charalambos Billinis, Laboratory of Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Thessaly, Karditsa, Greece, E-mail: billinis@vet.uth.gr. Christos Hadjichristodoulou, Department of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece, E-mail: xhatzi@med.uth.gr.
Mavrouli M, Vrioni G, Vlahakis A, Kapsimali V, Mavroulis S, Antypas A, Tsakris A, 2015. West Nile virus: biology, transmission, clinical manifestations, diagnosis, therapeutic approaches, climatic correlates and prevention. Acta Microbiol Hellenica 60: 7ā34.
Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, Davis B, Bowen R, Bunning M, 2003. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9: 311ā322.
Molaei G, Andreadis TG, Armstrong PM, Anderson JF, Vossbrinck CR, 2006. Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis 12: 468ā474.
Marka A et al. 2013. West Nile virus state of the art report of MALWEST project. Int J Environ Res Public Health 10: 6534ā6610.
Colpitts TM, Conway MJ, Montgomery RR, Fikrig E, 2012. West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev 25: 635ā648.
Petersen LR, Marfin AA, 2002. West Nile virus: a primer for the clinician. Ann Intern Med 137: 173ā179.
Smithburn KC, Hughes TP, Burke AW, Paul JH, 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 20: 471ā473.
Gubler DJ, 2007. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45: 1039ā1046.
Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI, 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet 352: 767ā771.
Platonov AE et al. 2001. Outbreak of West Nile virus infection, Volgograd region, Russia, 1999. Emerg Infect Dis 7: 128ā132.
Nash D et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807ā1814.
Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R, 2010. Epidemiology of West Nile in Europe and in the Mediterranean basin. Open Virol J 4: 29ā37.
Papa A et al. 2010. Ongoing outbreak of West Nile virus infections in humans in Greece, JulyāAugust 2010. Euro Surveill 15: 1ā5, pii: 19644.
Danis K et al. 2011. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis 17: 1868ā1872.
Vrioni G, Mavrouli M, Kapsimali V, Stavropoulou A, Detsis M, Danis K, Tsakris A, 2014. Laboratory and clinical characteristics of human West Nile virus infections during 2011 outbreak in southern Greece. Vector Borne Zoonotic Dis 14: 52ā58.
Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE, 2004. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol 42: 4641ā4648.
Prince HE, Lapeā-Nixon M, Moore RJ, Hogrefe WR, 2004. Utility of the focus technologies West Nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid. J Clin Microbiol 42: 12ā15.
Hadjichristodoulou C et al. 2015. West Nile Virus seroprevalence in the Greek population in 2013: a nationwide cross-sectional survey. PLoS One 10: e0143803.
Paz S, Semenza JC, 2013. Environmental drivers of West Nile fever epidemiology in Europe and western Asiaāa review. Int J Environ Res Public Health 10: 3543ā3562.
Lanciotti RS et al. 1999. Origin of West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333ā2337.
Papa A, Bakonyi T, Xanthopoulou K, Vazquez A, Tenorio A, Nowotny N, 2011. Genetic characterization of West Nile virus lineage 2, Greece 2010. Emerg Infect Dis 17: 920ā922.
Barzon L et al. 2013. Genome sequencing of West Nile virus from human cases in Greece, 2012. Viruses 5: 2311ā2319.
Danis K et al. 2011. Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill 16: 1ā5, pii: 19951.
Chaintoutis SC, Gewehr S, Mourelatos S, Dovas CI, 2016. Serological monitoring of backyard chickens in central Macedonia-Greece can detect low transmission of West Nile virus in the absence of human neuroinvasive disease cases. Acta Trop 163: 26ā31.
ECDC, 2017. West Nile FeverāAnnual Epidemiological Report for 2015. Available at: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-West-Nile-fever.pdf. Accessed April 10, 2018.
Nur YA, Groen J, Heuvelmans H, Tuynman W, Copra C, Osterhaus AD, 1999. An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg 61: 885ā888.
ECDC, 2018. Epidemiological Update: West Nile Virus Transmission Season in Europe, 2017. Available at: https://ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-virus-transmission-season-europe-2017. Accessed April 10, 2018.
Anis E, Grotto I, Mendelson E, Bin H, Orshan L, Gandacu D, Warshavsky B, Shinar E, Slater PE, Lev B, 2014. West Nile fever in Israel: the reemergence of an endemic disease. J Infect 68: 170ā175.
Bernabeu-Wittel M, Ruiz-Perez M, del Toro MD, Aznar J, Muniain A, de Ory F, Domingo C, Pachon J, 2007. West Nile virus past infections in the general population of southern Spain. Enferm Infecc Microbiol Clin 25: 561ā565.
Pervanidou D et al. 2014. West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission. Euro Surveill 19: 1ā11, pii: 20758.
Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, 2002. West Nile virus. Lancet Infect Dis 2: 519ā529.
Murray K et al. 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325ā1332.
Pezzotti P et al. 2011. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill 16: 1ā5, pii: 19814.
Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR, 2011. Flavivirus-induced antibody cross-reactivity. J Gen Virol 92: 2821ā2829.
Gaibani P, Rossini G, 2017. An overview of Usutu virus. Microbes Infect 19: 382ā387.
Chaintoutis SC et al. 2014. Evaluation of a West Nile virus surveillance and early warning system in Greece, based on domestic pigeons. Comp Immunol Microbiol Infect Dis 37: 131ā141.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 51 | 51 | 10 |
Full Text Views | 532 | 126 | 1 |
PDF Downloads | 218 | 49 | 1 |